M. Faner Canet (Barcelona, Spain), E. Papakonstantinou (Thessaloniki, Greece)
Influence of bacteria from the COPD lung microbiome on cigarette smoke-induced pro-inflammatory responses of three-dimensional lung epithelial cell cultures q. ni (Ghent, Belgium), C. Rigauts (Ghent, Belgium), L. Ostyn (Ghent, Belgium), E. Vandeplassche (Ghent, Belgium), G. Brusselle (Ghent, Belgium), T. Coenye (Ghent, Belgium), K. Bracke (Ghent, Belgium), A. Crabbé (Ghent, Belgium)
| |
Non-typeable Haemophilus influenzae infection of ciliated epithelium from healthy and chronic obstructive pulmonary disease donors A. Petris (London, United Kingdom), S. Velkova (London, United Kingdom), D. Lee (London, United Kingdom), S. Beinke (Stevenage, United Kingdom), R. Williamson (Stevenage, United Kingdom), N. Belyaev (Stevenage, United Kingdom), E. Hessel (Stevenage, United Kingdom), D. Moulding (London, United Kingdom), T. Mchugh (London, United Kingdom), P. Freestone (Leicester, United Kingdom), C. Smith (London, United Kingdom), C. O'Callaghan (London, United Kingdom)
| |
Volatile organic compound (VOC) analysis to differentiate between bacterial and viral respiratory infections in COPD F. Kamal (London, United Kingdom), S. Kumar (London, United Kingdom), A. Singanayagam (London, United Kingdom), M. Edwards (London, United Kingdom), A. Romano (London, United Kingdom), K. Veslkov (London, United Kingdom), I. Laponogov (London, United Kingdom), G. Donaldson (London, United Kingdom), S. Johnston (London, United Kingdom), J. Wedzicha (London, United Kingdom), G. Hanna (London, United Kingdom)
| |
Utility of CAT questionnaire in the diagnosis of bacterial colonization in Bronchiectasis A. Feliu (Barcelona, Spain), A. Rodrigo-Troyano (Barcelona, Spain), L. Perea (Barcelona, Spain), J. Giner (Barcelona, Spain), D. Castillo (Barcelona, Spain), F. Sánchez-Reus (Barcelona, Spain), D. De La Rosa (Barcelona, Spain), M. Martínez-García (Valencia, Spain), O. Sibila Vidal (Barcelona, Spain)
| |
Longitudinal profiling of viral infections in COPD patients and their implication to exacerbations D. Stolz (Basel, Switzerland), H. Hirsch (Basel, Switzerland), D. Schilter (Bern, Switzerland), R. Louis (Liege, Belgium), J. Rakic (Basel, Switzerland), L. Boeck (Basel, Switzerland), E. Papakonstantinou (Basel, Switzerland), C. Schindler (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland)
| |
Sputum biospecimen quality and suitability for microbiome characterisation in COPD J. Shaw (Chermside, Australia), H. O'Farrell (Chermside, Australia), O. Ferry (Chermside, Australia), P. Fung (Chermside, Australia), D. Courtney (Chermside, Australia), R. Bowman (Chermside, Australia), K. Fong (Chermside, Australia), I. Yang (Chermside, Australia)
| |
Moraxella catarrhalis infection of healthy and COPD ciliated epithelial cultures S. Velkova (London, United Kingdom), A. Petris (London, United Kingdom), D. Lee (London, United Kingdom), P. Freestone (Leicester, United Kingdom), R. Williamson (Stevenage, United Kingdom), S. Beinke (Stevenage, United Kingdom), N. Belyaev (Stevenage, United Kingdom), E. Hessel (Stevenage, United Kingdom), D. Moulding (London, United Kingdom), R. Smyth (London, United Kingdom), C. Smith (London, United Kingdom), C. O'Callaghan (London, United Kingdom)
| |
Relationship between the respiratory microbiome and systemic patterns in COPD L. Millares Costas (Sabadell, Spain), S. Pascual (Barcelona, Spain), C. Lalmolda (Sabadell, Spain), M. García-Nuñez (Sabadell, Spain), R. Faner (Barcelona, Spain), C. Casadevall (Barcelona, Spain), L. Seto (Sabadell, Spain), O. Cuevas (Sabadell, Spain), S. Capilla (Sabadell, Spain), A. Moreno (Sabadell, Spain), A. Castro (Madrid, Spain), C. Alvarez (Madrid, Spain), O. Sibila (Madrid, Spain), G. Peces-Barba (Madrid, Spain), B. Cosio (Mallorca, Spain), C. Monton (Sabadell, Spain), A. Agusti (Barcelona, Spain), J. Gea (Barcelona, Spain), E. Monsó (Barcelona, Spain)
| |
What is the best technique to extract bacterial DNA from sputum? M. Oriano (Milan, Italy), L. Terranova (Milan, Italy), L. Ruggiero (Milan, Italy), C. Tafuro (Milan, Italy), A. Teri (Milan, Italy), L. Cariani (Milan, Italy), E. Franceschi (Milan, Italy), F. Amati (Milan, Italy), A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), J. Chalmers (Dundee, United Kingdom), P. Marchisio (Milan, Italy), S. Aliberti (Milan, Italy), F. Blasi (Milan, Italy)
| |
Diagnosis of Lower Respiratory Tract Infections using nanopore sequencing T. Charalampous (Norwich, United Kingdom), H. Richardson (Norwich, United Kingdom), G. Kay (Norwich, United Kingdom), R. Baldan (Norwich, United Kingdom), C. Jeanes (Norwich, United Kingdom), D. Turner (Oxford, United Kingdom), J. Wain (Norwich, United Kingdom), D. Livermore (Norwich, United Kingdom), R. Leggett (Norwich, United Kingdom), J. O'Grady (Norwich, United Kingdom)
| |
Respiratory syncytial virus (RSV) disease in hospitalised adults in Europe with COPD: Impact of GOLD score on RSV disease burden T. Harrer (Paris, France), F. Thalhammer (Vienna, Austria), O. Launay (Erlangen, Germany), A. Cheret (Issy-les-Moulineaux, France), G. De La Rosa (Raritan, United States of America), I. Sander (Cambridge, United States of America), R. Stolper (Cambridge, United States of America), J. Zakar (Cambridge, United States of America), K. Weber (Vienna, Austria)
| |
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD L. Finney (London, United Kingdom), K. Belchamber (London, United Kingdom), P. Fenwick (London, United Kingdom), S. Kemp (London, United Kingdom), S. Johnston (London, United Kingdom), L. Donnelly (London, United Kingdom), J. Wedzicha (London, United Kingdom)
| |
Comparing Respiratory Pathogen in patients with non-Cystic Fibrosis bronchiectasis during clinically stable and exacerbation C. SIVAKORN (Bangkok, Thailand), V. Wongsrichanalai (Bangkok, Thailand)
| |
Tsukamurella species isolation in bronchiectasis and chronic obstructive pulmonary disease patients: A retrospective case series E. Amara Elori (Valencia, Spain), R. Méndez Ocaña (Valencia, Spain), A. Gil Brusola (Valencia, Spain), B. Montull Veiga (Valencia, Spain), A. Gimeno Cardells (Valencia, Spain), A. Piró Dorado (Valencia, Spain), P. González Jiménez (Valencia, Spain), L. Feced Olmos (Valencia, Spain), P. Falomir Salcedo (Valencia, Spain), R. Menéndez Villanueva (Valencia, Spain)
| |
Characterization of macrophages from bronchoalveolar lavage of COPD patients with and without bacterial colonization L. Perea (Barcelona, Spain), E. Cantó (Barcelona, Spain), A. Rodrigo-Troyano (Barcelona, Spain), A. Torrego (Barcelona, Spain), J. Giner (Barcelona, Spain), A. Feliu (Barcelona, Spain), F. Sánchez-Reus (Barcelona, Spain), S. Vidal (Barcelona, Spain), O. Sibila Vidal (Barcelona, Spain)
| |
Development of antibiotic-resistance in P. aeruginosa obtained from bronchiectasis patients: a multicenter prospective observational study P. Faverio (Monza, Italy), G. Bonaiti (Monza, Italy), S. Zucchetti (Monza, Italy), A. Stainer (Monza, Italy), E. Franceschi (Milan, Italy), A. Rodrigo Troyano (Barcelona, Spain), O. Sibila (Barcelona, Spain), F. Bini (Garbagnate Milanese, Italy), B. Dino Bodini (Novara, Italy), S. Aliberti (Milan, Italy)
| |
Tolerance test for inhaled antibiotics in patients with chronic bronchial infection E. Barbero Herranz (Madrid, Spain), R. Nieto Royo (Madrid, Spain), R. Morillo Guerrero (Madrid, Spain), D. Barrios Barreto (Madrid, Spain), C. Almonacid Sánchez (Madrid, Spain), F. León Román (Madrid, Spain), L. Maíz Carro (Madrid, Spain)
| |
Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities C. Duarte Ferreira Dantas (Lisbon, Portugal), D. Silva (Lisbon, Portugal), I. Duarte (Lisbon, Portugal), R. Bernardes (Lisbon, Portugal), T. Sá (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal)
| |